Share this video  

SABCS 2021 | Future research directions for ER+ positive breast cancer

Hiroji Iwata, MD, PhD, Aichi Cancer Center Hospital, Nagoya, Japan, discusses the future of research into estrogen receptor-positive (ER+) HER2-negative breast cancer, including investigation into which patients are good candidates for adjuvant endocrine therapy. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter